The 45th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT), took place in Frankfurt, Germany, from the 24–27 of March 2019. The latest research and education in the field of bone marrow transplantation was explored, discussed and debated.

EBMT 2019

24–27 March 2019 | Frankfurt, Germany

EBMT 2019

24–27 March 2019 | Frankfurt, Germany

The 45th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT), took place in Frankfurt, Germany, from the 24–27 of March 2019. The latest research and education in the field of bone marrow transplantation was explored, discussed and debated.

MRD testing in the clinical setting: challenges in practice 2:56
MRD testing in the clinical setting: challenges in practice
Robin Foà
What clinicians need to know about MRD testing for acute leukemias 1:53
What clinicians need to know about MRD testing for acute leukemias
Robin Foà
The importance of QoL in guiding myeloma therapy 1:33
The importance of QoL in guiding myeloma therapy
Karthik Ramasamy
Flow cytometry vs. molecular methods for MRD testing in acute leukemias 2:32
Flow cytometry vs. molecular methods for MRD testing in acute leukemias
Robin Foà
Current challenges in myeloma therapy 1:08
Current challenges in myeloma therapy
Karthik Ramasamy
The aims of the Patvocates Network 0:53
The aims of the Patvocates Network
Jan Geissler
The importance of patient advocacy tracks at congresses 1:28
The importance of patient advocacy tracks at congresses
Jan Geissler
The evolution of patient advocacy 1:14
The evolution of patient advocacy
Jan Geissler
Treatment considerations at first relapse after transplantation 2:40
Treatment considerations at first relapse after transplantation
Maria-Victoria Mateos
Utilizing health resources 1:51
Utilizing health resources
Karthik Ramasamy
The need for patient advocates to attend major congresses such as EBMT 1:21
The need for patient advocates to attend major congresses such as EBMT
Jan Geissler
Maintenance therapy in patients with myeloma 2:17
Maintenance therapy in patients with myeloma
Maria-Victoria Mateos
The role of the nurse clinician in the management of GvHD 2:32
The role of the nurse clinician in the management of GvHD
John Murray
The value of MRD testing in transplant-eligible patients 2:16
The value of MRD testing in transplant-eligible patients
Maria-Victoria Mateos
Education initiatives for CAR T-cell therapy 1:36
Education initiatives for CAR T-cell therapy
John Murray
The 1st patient advocacy track at EBMT: making a difference for patients 1:08
The 1st patient advocacy track at EBMT: making a difference for patients
Anita Waldmann

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals